1. MEF2C promotes gefitinib resistance in hepatic cancer cells through regulating MIG6 transcription. Issue 3 (June 2018) Authors: Zhang, Hui; Liu, Wei; Wang, Zhi; Meng, Lin; Wang, Yunhua; Yan, Huawu; Li, Lin Journal: Tumori Issue: Volume 104:Issue 3(2018) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗